ADAI Symposium: Short and Long-Term Risks of High-THC Products (AM Panel)

Описание: The Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington hosted the "High-THC Cannabis in Legal Regulated Markets" symposium on September 16, 2022. This event was held for the public, researchers, policymakers, and other stakeholders to learn about the short and long-term risks of high-THC products, including conversations about policy-focused solutions and ways to increase awareness through education campaigns for providers, parents, and youth. Speakers include a range of international, national, and regional experts.

This video features the AM panel discussion:

Introductions: State Rep. Lauren Davis (D-Shoreline)
Moderator: Tracy Klein, PhD, ARNP, FAANP, FRE, FAAN

0:00:00-0:00:47 Introduction

"High-THC Products: Public Health Outcomes in Legal Markets"
0:00:47-0:20:55 Julia Dilley, PhD

"Acute Effects of High-Potency Cannabis Flower and Concentrates on Cognition"
0:20:55-0:43:43 Carrie Cuttler, PhD

"Cannabis Use by Young Adults: Trends and Considerations"
0:43:43-1:04:27 Jason Kilmer, PhD

"Cannabis Use & Psychiatric Comorbidity: Epidemiology & Association with High-Potency Cannabis"
1:04:27-1:23:19 Deborah Hasin, PhD

"Recommendations for Regulating High-Potency Cannabis in Recreational Markets and Why"
1:23:19-1:50:00 Rosalie Pacula, PhD

1:50:00-2:04:10 Panel Q&A

-----------------------------------------------------------
Watch the full event here:    • ADAI Symposium: High-THC Cannabis in Legal...  

This symposium’s focus was on high-THC products sold for non-medical use in the market regulated by the WSLCB. The use of cannabis as a medicine should be decided by individuals and their health care providers.